Literature DB >> 22951826

Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells.

Wenjing Li1, Bruno Moltedo, Thomas M Moran.   

Abstract

The majority of deaths following influenza virus infection result from secondary bacterial superinfection, most commonly caused by Streptococcus pneumoniae. Several models have been proposed to explain how primary respiratory viral infections exacerbate secondary bacterial disease, but the mechanistic explanations have been contradictory. In this study, mice were infected with S. pneumoniae at different days after primary influenza A (X31) virus infection. Our findings show that the induction of type I interferons (IFNs) during a primary nonlethal influenza virus infection is sufficient to promote a deadly S. pneumoniae secondary infection. Moreover, mice deficient in type I interferon receptor (IFNAR knockout [KO] mice) effectively cleared the secondary bacterial infection from their lungs, increased the recruitment of neutrophils, and demonstrated an enhanced innate expression of interleukin-17 (IL-17) relative to wild-type (WT) mice. Lung γδ T cells were responsible for almost all IL-17 production, and their function is compromised during secondary S. pneumoniae infection of WT but not IFNAR KO mice. Adoptive transfer of γδ T cells from IFNAR KO mice reduced the susceptibility to secondary S. pneumoniae infection in the lung of WT mice. Altogether, our study highlights the importance of type I interferon as a key master regulator that is exploited by opportunistic pathogens such as S. pneumoniae. Our findings may be utilized to design effective preventive and therapeutic strategies that may be beneficial for coinfected patients during influenza epidemics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22951826      PMCID: PMC3486468          DOI: 10.1128/JVI.01269-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity.

Authors:  Bruno Moltedo; Carolina B López; Michael Pazos; María Inés Becker; Tamar Hermesh; Thomas M Moran
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

Review 2.  Of mice and men: innate immunity in pneumococcal pneumonia.

Authors:  Esther Calbo; Javier Garau
Journal:  Int J Antimicrob Agents       Date:  2009-12-14       Impact factor: 5.283

3.  Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung.

Authors:  Cherrie-Lee Small; Christopher R Shaler; Sarah McCormick; Mangalakumari Jeyanathan; Daniela Damjanovic; Earl G Brown; Petra Arck; Manel Jordana; Charu Kaushic; Ali A Ashkar; Zhou Xing
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

4.  A protective function for interleukin 17A in T cell-mediated intestinal inflammation.

Authors:  William O'Connor; Masahito Kamanaka; Carmen J Booth; Terrence Town; Susumu Nakae; Yoichiro Iwakura; Jay K Kolls; Richard A Flavell
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

Review 5.  Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system.

Authors:  Russell E Vance; Ralph R Isberg; Daniel A Portnoy
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

6.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Authors:  Arash Shahangian; Edward K Chow; Xiaoli Tian; Jason R Kang; Amir Ghaffari; Su Y Liu; John A Belperio; Genhong Cheng; Jane C Deng
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

7.  Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-10-02       Impact factor: 17.586

8.  Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses.

Authors:  Markus Mordstein; Georg Kochs; Laure Dumoutier; Jean-Christophe Renauld; Søren R Paludan; Kevin Klucher; Peter Staeheli
Journal:  PLoS Pathog       Date:  2008-09-12       Impact factor: 6.823

9.  Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus.

Authors:  Hannah Phipps-Yonas; Jeremy Seto; Stuart C Sealfon; Thomas M Moran; Ana Fernandez-Sesma
Journal:  PLoS Pathog       Date:  2008-10-31       Impact factor: 6.823

10.  Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses.

Authors:  Gang Qin; Huawei Mao; Jian Zheng; Sin Fun Sia; Yinping Liu; Ping-Lung Chan; Kwok-Tai Lam; J S Malik Peiris; Yu-Lung Lau; Wenwei Tu
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

View more
  102 in total

Review 1.  The immunology of influenza virus-associated bacterial pneumonia.

Authors:  Keven M Robinson; Jay K Kolls; John F Alcorn
Journal:  Curr Opin Immunol       Date:  2015-02-24       Impact factor: 7.486

2.  IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and Streptococcus pneumoniae Coinfection.

Authors:  Shruti Bansal; Vijaya Kumar Yajjala; Christopher Bauer; Keer Sun
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

3.  Interferon Lambda Inhibits Bacterial Uptake during Influenza Superinfection.

Authors:  Helen E Rich; Collin C McCourt; Wen Quan Zheng; Kevin J McHugh; Keven M Robinson; Jieru Wang; John F Alcorn
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

4.  Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice.

Authors:  Benjamin Lee; Keven M Robinson; Kevin J McHugh; Erich V Scheller; Sivanarayana Mandalapu; Chen Chen; Y Peter Di; Michelle E Clay; Richard I Enelow; Patricia J Dubin; John F Alcorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

Review 5.  Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia.

Authors:  Jennifer A Grousd; Helen E Rich; John F Alcorn
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

6.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

7.  M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.

Authors:  D G Eliasson; A Omokanye; K Schön; U A Wenzel; V Bernasconi; M Bemark; A Kolpe; K El Bakkouri; T Ysenbaert; L Deng; W Fiers; X Saelens; N Lycke
Journal:  Mucosal Immunol       Date:  2017-03-01       Impact factor: 7.313

Review 8.  Lung-resident γδ T cells and their roles in lung diseases.

Authors:  Min Cheng; Shilian Hu
Journal:  Immunology       Date:  2017-06-20       Impact factor: 7.397

Review 9.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

10.  Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia.

Authors:  Agnieszka Rynda-Apple; Ann Harmsen; Anfin S Erickson; Kyle Larson; Rachelle V Morton; Laura E Richert; Allen G Harmsen
Journal:  Eur J Immunol       Date:  2014-09-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.